However, it has also been shown that ASCL1 and NEUROD1 function as independent lineage-specific oncogenes that drive distinct gene expression programs, and thereby influence the pathogenesis, prognosis, and therapeutic responses of each individual SCLC case. Here, ASCL1 is linked to small cell lung carcinoma.